Company news

Terumo Corporation news in 2026

Terumo Corporation's news releases, calls and decks from 2026, newest first.

View company

Terumo and the University of Oxford launch six-year partnership to advance organ perfusion technologies

October 14, 2026

Decision Regarding the Termination of the Supply Agreement with CSL Plasma (with note)

October 8, 2026

Notice Concerning Recognition of Losses Resulting from the Termination of a Supply Agreement with a Major Customer and the Revision of Consolidated Fi

October 8, 2026

6 countries across Terumo Asia Pacific officially recognized as Best Workplaces™ Certified by Great Place To Work®

September 20, 2026

Terumo Neuro Announces Two WISE Study Publications Reporting 0% New Bleeds or Rebleeds Through One Year Following WEB™ Treatment in Ruptured and Unruptured Aneurysm Cohorts

August 31, 2026

Notice Concerning Change in Subsidiary

August 21, 2026

Consolidated Financial Results for the Three Months Ended June 30, 2026〔IFRS〕

August 7, 2026

Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)

August 4, 2026

Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration

July 16, 2026

Terumo Announces Voluntary Recall of Specific Models of the Relay™Pro Thoracic Stent-Graft System in Global Markets

July 1, 2026

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

June 29, 2026

Financial Results for the Fiscal Year Ended March 31, 2026 (FY2025)(with note)

May 18, 2026

Financial Results for the Fiscal Year Ended March 31, 2026 (FY2025)

May 15, 2026

IFRS Financial Results for the Fiscal Year Ended March 31, 2026

May 15, 2026

Terumo Announces Candidates for Directors

May 15, 2026

Terumo: Issued its First U.S. Dollar-Denominated Senior Unsecured Notes

April 29, 2026

Terumo Corporation Joins the Healthcare Plastics Recycling Council

April 15, 2026

Tata Elxsi Announces the Launch of a Global Offshore Development Center (ODC) for Terumo Corporation

March 19, 2026

Terumo Blood and Cell Technologies introduces APAC C&GT Ecosystem Blueprint

March 4, 2026

Q&A Session at the Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026

February 16, 2026

Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (FY2025)(with note)

February 16, 2026

Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (FY2025)

February 13, 2026

IFRS Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026

February 13, 2026

Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology

January 6, 2026

Calls in 2026

Decks in 2026